Cracking Cancer 2.0 - Cancer Innovation - The Long View

Karl Koster
Executive Director
MIT Corporate Relations

Cracking Cancer 2.0 - Introductory Remarks
Trond Undheim, PhD, Anne Deconinck, PhD

Startup lightning talks for Travera, Honeycomb, PanTher Therapeutics, Torque, Elektrofi;, Sextant, Leuko Labs, and Asimov.

Erik Vogan, PhD, MBA
Program Director
MIT Corporate Relations Industrial Liaison Program

Panel discussion moderated by Trond Undheim, Program Director, MIT Startup Exchange. Panelists include: Paula Hammond, PhD, David H. Koch Professor in Engineering, Department Head, Chemical Engineering, MIT, ; Laura Indolfi, PhD, CEO of PanTher Therapeutics; and Peter Sandor, VP, Head of Oncology Marketing Strategy, Astellas.